Explore/

Cannabis Stocks

Cannabis Stocks

39.31k followers23 symbols +5.41% Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

23 Symbols

To view complete list, get the Yahoo Finance App

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • The Craziest Marijuana Statistic of 2018
    Motley Fool3 hours ago

    The Craziest Marijuana Statistic of 2018

    Despite no shortage of cannabis milestones, it was an odd year for pot stocks.

  • 2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb
    Motley Fool6 hours ago

    2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb

    Is cannabis policy reform at the federal level "inevitable?"

  • 3 Top Stocks to Buy in December
    Motley Fool6 hours ago

    3 Top Stocks to Buy in December

    These stocks have one common denominator: Great long-term growth prospects.

  • Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think
    Motley Fool6 hours ago

    Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think

    There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.

  • Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
    Motley Fool6 hours ago

    Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals

    Which stock wins in a matchup between this top Canadian marijuana grower and the biggest cannabis-focused biotech?

  • Did Gilead Sciences Make an $11 Billion Blunder?
    Motley Fool8 hours ago

    Did Gilead Sciences Make an $11 Billion Blunder?

    Spoiler alert: The answer is "no."

  • Is It Time to Buy Marijuana Stocks?
    The Motley Fool19 hours ago

    Is It Time to Buy Marijuana Stocks?

    Marijuana stocks continue their wild ride as Altria Group Inc. (TSX:MO) buys 45% stake in Cronos Group Inc. (TSX:CRON) (NYSE:CRON) and take them higher on Friday after a week of continued marijuana stock carnage.

  • Here's Why Scotts Miracle-Gro Rose 13.8% in November
    Motley Fool21 hours ago

    Here's Why Scotts Miracle-Gro Rose 13.8% in November

    The home garden specialist announced fiscal 2018 earnings and issued upbeat guidance for fiscal 2019.

  • Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings
    Motley Foolyesterday

    Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings

    Which stock wins in a matchup between a big marijuana producer and a top ancillary products supplier to the cannabis industry?

  • 4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
    Motley Foolyesterday

    4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt

    Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.

  • Have Weed Stocks Replaced Bitcoin?
    The Motley Foolyesterday

    Have Weed Stocks Replaced Bitcoin?

    Lessons that Canopy Growth Corporation (TSX:WEED) can learn from cryptocurrencies

  • Better Buy: Scotts Miracle-Gro vs. Lowe's
    Motley Fool2 days ago

    Better Buy: Scotts Miracle-Gro vs. Lowe's

    There are two factors to consider when looking at Lowe's and Miracle-Gro: recent performance and marijuana.

  • A Look at AbbVie’s Earnings Projections for 2018
    Market Realist2 days ago

    A Look at AbbVie’s Earnings Projections for 2018

    On its third-quarter earnings conference call, AbbVie (ABBV) raised its adjusted EPS guidance for 2018 from its previous projection of $7.76–$7.86 to $7.90–$7.92. The revised estimate implies a YoY (year-over-year) rise of 41.3% considering the midpoint of the guidance range. As per the company’s third-quarter earnings conference call, AbbVie expects its adjusted fourth-quarter EPS to be in the range of $1.89–$1.91 excluding a $0.26 impact of noncash amortization and other items.

  • The Canadian Press2 days ago

    Most actively traded companies on the TSX

    Some of the most active companies traded Friday on the Toronto Stock Exchange:

  • Why Aphria Tanked Over 11% Today
    Market Realist2 days ago

    Why Aphria Tanked Over 11% Today

    Today, Aphria (APHA)(APHQF) resumed a sharp sell-off in its stock from early this month after surging a whopping 51% yesterday. Now, let’s find out what could be driving Aphria stock down today. Grego alleged that “Aphria had diverted funds into inflated investments held by insiders.” Since then, these allegations have taken a massive toll on investors’ confidence.

  • Assessing AbbVie’s 2018 Revenue Projections
    Market Realist2 days ago

    Assessing AbbVie’s 2018 Revenue Projections

    On its third-quarter earnings conference call, AbbVie (ABBV) raised its net revenue guidance for 2018 from its previous projection of $32.5 billion to $32.7 billion. The company also raised its forecast for YoY (year-over-year) operational revenue growth in 2018 from 14.5% to 15.0%. As per AbbVie’s third-quarter earnings conference call, the company expects a favorable revenue impact of less than 1% due to foreign currency fluctuations in 2018.

  • Aurora Cannabis to supply medical pot to Mexico through partnership
    The Canadian Press2 days ago

    Aurora Cannabis to supply medical pot to Mexico through partnership

    EDMONTON — Aurora Cannabis says it will supply medical cannabis to Mexico through a partnership with pharmaceutical manufacturer and distributor Farmacias Magistrales.

  • Reuters2 days ago

    Aurora Cannabis to supply medical marijuana to Mexico

    "This new exclusive partnership further expands Aurora's early mover advantage in Latin America," Chief Executive Officer Terry Booth said in a statement. Farmacias has a reach of about 80,000 retail points and 500 pharmacies and hospitals across Mexico, the company said. The announcement comes a month after Mexico's Congress website showed its plans to submit a bill to create a medical marijuana industry and allow recreational use in what would be a big step by the incoming government to shake up the country's drug war.

  • Analysts’ Recommendations for AbbVie in December
    Market Realist2 days ago

    Analysts’ Recommendations for AbbVie in December

    The company saw a rise of 17.53% in its share price from $80.21 on November 1 to $94.27 on November 30. Thereafter, AbbVie saw a 3.95% fall in its share price from November 30 to December 5. On November 30, AbbVie issued a press release announcing agreements that granted Pfizer (PFE) a nonexclusive global license related to Humira’s intellectual property.

  • Investing.com2 days ago

    AbbVie Falls 4%

    Investing.com - AbbVie (NYSE:ABBV) fell by 4.11% to trade at $86.620 by 11:29 (16:29 GMT) on Friday on the NYSE exchange.

  • Short Seller Not Backing Down on Aphria
    Market Realist2 days ago

    Short Seller Not Backing Down on Aphria

    On December 6, Aphria’s (APHQF) short seller, Hindenburg Research, released its Part 2 on what it found to be further malice in the company’s acquisition efforts. According to the research, this acquisition showed a 5 million Canadian dollar gain to Aphria’s insider in a matter of six days. Further, the report pointed out that Aphria’s CEO, Vic Neufeld, was also a part of the “discount round” in which Aphria purchased companies at overpriced valuations. Even more damning was the short seller’s observation that the SEC had alleged that the individuals that Aphria purchased companies from were involved in pump and dump schemes.

  • Weed CEO: 'Edibles suffer from 3 major problems'
    Yahoo Finance2 days ago

    Weed CEO: 'Edibles suffer from 3 major problems'

    Edibles still quite aren't mainstream for various reasons, an edibles CEO tells Yahoo Finance recently on the Final Round.

  • Stocks tumble, oil surges on OPEC deal
    Yahoo Finance2 days ago

    Stocks tumble, oil surges on OPEC deal

    Yahoo Finance's LIVE market coverage and analysis, beginning each day at 11:30 a.m. ET.

  • Beware: Canopy Growth Corp. (TSX:WEED) Is Cheaper, but Not Cheap
    The Motley Fool2 days ago

    Beware: Canopy Growth Corp. (TSX:WEED) Is Cheaper, but Not Cheap

    Even though the stock has come down significantly in price, Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) is cheaper than it once was, but it is by no means cheap.

  • Aphria’s Announcement of Special Committee Pauses Sell-Off
    Market Realist2 days ago

    Aphria’s Announcement of Special Committee Pauses Sell-Off

    Aprhia (APHQF) recovered by nearly 50% on December 6 due to its further commitment to relieve investors’ fears related to its Latin America business. The company appointed a special committee that consists of independent directors who will be tasked with reviewing the legitimacy of the company’s acquisitions in Latin America. The above chart shows that Aphria (APHQF) is among the top ten holdings in the Horizons Marijuana Life Sciences ETF (HMMJ).